Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$656,743,153
+$257,673,346 QoQ
Shares Held
547,546
+26.2% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#117
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$4,083,784
PutShares
3,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $2,173,508,170 across 16 Drug Manufacturers - General names. LLY ranks #1 (30.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
547,546 | $656,743,153 | |
| 2 | JNJ |
Johnson & Johnson
|
1,756,229 | $446,029,479 | |
| 3 | ABBV |
AbbVie Inc.
|
1,138,736 | $286,551,527 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,523,212 | $195,732,742 | |
| 5 | AMGN |
Amgen Inc
|
425,632 | $154,129,859 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
722,993 | $91,342,935 | |
| 7 | PFE |
Pfizer Inc
|
2,712,410 | $65,314,832 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,121,564 | $64,624,517 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $656,743,153 | 547,546 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $399,069,807 | 433,880 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $397,460,762 | 369,841 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $4,083,784 | 3,800 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $169,353,954 | 221,958 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $113,429,410 | 145,510 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $3,507,885 | 4,500 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $93,140,348 | 112,773 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $51,392,040 | 66,570 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $54,279,771 | 61,268 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $43,517,995 | 48,066 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,143,243 | 46,459 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $18,553,177 | 31,828 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,124,506 | 28,158 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,027,261 | 21,381 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $4,439,390 | 12,927 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $6,599,753 | 18,040 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,852,917 | 8,823 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,625,290 | 8,097 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $689,578 | 2,408 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,425,764 | 8,782 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||